Acrivon Therapeutics, Inc. Common Stock Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 8.34 M | $50.21 M | 0.00% | 21.89% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 5.36 M | $32.27 M | 0.00% | 14.07% |
| SANDS CAPITAL VENTURES, LLC | 02/13/2025 | 2.12 M | $12.78 M | 0.00% | 5.57% |
| CITADEL ADVISORS LLC | 02/14/2025 | 2.12 M | $12.76 M | -0.98% | 5.56% |
| BLACKROCK, INC. | 02/07/2025 | 945,496 | $5.69 M | 20.14% | 2.48% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 888,130 | $5.35 M | 0.00% | 2.33% |
| MARSHALL WACE, LLP | 02/13/2025 | 597,794 | $3.60 M | -26.19% | 1.57% |
| 02/14/2025 | 405,237 | $2.44 M | 100.00% | 1.06% | |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 301,389 | $1.81 M | -0.24% | 0.79% |
| NORTHERN TRUST CORP | 02/14/2025 | 117,323 | $706,284 | 11.31% | 0.31% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 112,414 | $676,732 | 0.00% | 0.30% |
| UBS OCONNOR LLC | 02/14/2025 | 102,784 | $618,760 | 29.70% | 0.27% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 74,600 | $449,092 | -3.09% | 0.20% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 52,885 | $318,368 | 0.00% | 0.14% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 49,400 | $297,388 | 7.63% | 0.13% |
| MORGAN STANLEY | 02/14/2025 | 34,731 | $209,081 | -3.29% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 31,106 | $187,258 | 3.81% | 0.08% |
| EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 20,348 | $122,495 | 0.00% | 0.05% |
| RHUMBLINE ADVISERS | 01/30/2025 | 17,755 | $106,875 | -0.03% | 0.05% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 17,588 | $105,880 | 14.19% | 0.05% |
| TREXQUANT INVESTMENT LP | 02/12/2025 | 16,871 | $101,563 | -44.47% | 0.04% |
| PALE FIRE CAPITAL SE | 02/13/2025 | 15,235 | $91,715 | 100.00% | 0.04% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 13,402 | $80,680 | -48.01% | 0.04% |
| CITIGROUP INC | 02/12/2025 | 12,332 | $74,238 | 9.95% | 0.03% |
| CORTON CAPITAL INC. | 02/14/2025 | 12,159 | $73,197 | 100.00% | 0.03% |
| 03/12/2025 | 10,857 | $65,359 | 100.00% | 0.03% | |
| AAF WEALTH MANAGEMENT, LLC | 02/18/2025 | 10,678 | $64,282 | 0.00% | 0.03% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 6,775 | $40,786 | 4.70% | 0.02% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 6,602 | $39,744 | 100.00% | 0.02% |
| COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 5,873 | $35,355 | -7.01% | 0.02% |
| FMR LLC | 02/13/2025 | 2,933 | $17,657 | 13.64% | 0.01% |
| NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 2,314 | $14,000 | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 1,766 | $10,631 | -62.86% | 0.00% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/27/2025 | 1,038 | $6,145 | 100.00% | 0.00% |
| LEGAL & GENERAL GROUP PLC | 02/13/2025 | 839 | $5,084 | 0.00% | 0.00% |
| 02/19/2025 | 654 | $3,937 | 100.00% | 0.00% | |
| 02/13/2025 | 500 | $3,010 | 100.00% | 0.00% | |
| STERLING CAPITAL MANAGEMENT LLC | 02/13/2025 | 401 | $2,414 | 983.78% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/14/2025 | 400 | $2,408 | 0.00% | 0.00% |
| AMALGAMATED BANK | 02/04/2025 | 378 | $2,000 | 0.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 100 | $602 | 100.00% | 0.00% |
| 02/06/2025 | 74 | $445 | 100.00% | 0.00% | |
| GAMMA INVESTING LLC | 01/03/2025 | 34 | $205 | 100.00% | 0.00% |
| 01/23/2025 | 20 | $120 | 100.00% | 0.00% | |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CAPITAL PERFORMANCE ADVISORS LLP | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
| EXOME ASSET MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Acrivon Therapeutics, Inc. Common Stock institutional Ownership - FAQ's
During the previous two years, 42 institutional investors and hedge funds held shares of Acrivon Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 8.34 M
PERCEPTIVE ADVISORS LLC: 5.36 M
Sands Capital Ventures, LLC: 2.12 M
CITADEL ADVISORS LLC: 2.12 M
BlackRock, Inc.: 945,496
WELLINGTON MANAGEMENT GROUP LLP: 888,130
60.39% of Acrivon Therapeutics, Inc. Common Stock stock is owned by institutional investors.
Institutional investors have bought a total of 22.45 M shares in the last 24 months. This purchase volume represents approximately $39.06 M in transactions.